The final report of the EOGRTS review project, published in March 2023, confirms the effectiveness of studies in identifying hazardous substances, with a focus on their impact on sexual function, fertility, and development. These studies are essential for classifying substances and identifying endocrine disruptors, helping to protect the health of parents and their children.
ECHA has also provided recommendations to improve the design and reporting of future studies. Specific aspects such as hormone measurements and anogenital distance have been further analysed through satellite projects to optimize testing practices and enhance chemical monitoring.
For more details, you can consult the full report on the ECHA website.
